Forbes: Senolytic therapies seem to stop Alzheimer’s disease ‘in its tracks’

Shared by

Scientists at the UT Health San Antonio have implicated a type of cellular stress for the first time as a player in Alzheimer’s disease.

Read the full story at Forbes


Share This Article!